Story behind controversial Alzheimer's drug

A new report by STAT is shedding light on the FDA's recent approval of the controversial Alzheimer's drug Aduhelm. Reporter Damian Garde joined CBSN to discuss what his investigation uncovered.

• Jul 2, 2021
• 05:00

Experts meeting on COVID-19 and kids

The CDC director will join doctors working with Johnson and Johnson, Pfizer, Moderna and the FDA to talk about the impact of COVID-19 on kids. The group will also discuss the role of pediatric vaccines and some of the uncertainties surrounding them. Internal medicine specialist and immunologist Dr. Neeta Ogden joined CBSN to discuss the meeting and the impact of the highly contagious Delta variant.

• Jun 30, 2021
• 07:31

Coronavirus cases rise in a dozen states

Coronavirus infections are rising in at least 12 states as the Delta variant spreads. As Janet Shamlian reports, experts warn some areas could see "very dense outbreaks." Then, Dr. Taison Bell, a critical care and infectious disease physician and the medical ICU director at the University of Virginia, joins CBSN's Mola Lenghi to discuss the latest.

• Jun 28, 2021
• 09:47

Hutchinson says final FDA approval of COVID-19 vaccine would help fight hesitancy

Arkansas Governor Asa Hutchinson says some of his constituents are reluctant to get vaccinated while the vaccines are only approved for emergency use.

• Jun 27, 2021
• 07:07

FDA will add warnings to Pfizer and Moderna vaccine fact sheets

The FDA will add warnings to Pfizer and Moderna coronavirus vaccine fact sheets after the CDC confirmed a likely link between the vaccine and heart inflammation in young adults. Laura Podesta joins CBSN AM with the latest.

• Jun 24, 2021
• 03:42

Some vaccines linked to rare heart conditions

The FDA is adding a warning to some coronavirus vaccines that have been linked to rare heart inflammation in young people. Despite that risk, experts are still recommending vaccinations for everyone 12 and older because complications from the virus could be more severe. Nikki Battiste reports.

• Jun 24, 2021
• 02:24

Heart condition tied to COVID-19 vaccines

Almost 400 teens and young adults have developed a heart condition after getting the Pfizer or Moderna vaccine. Dr. Tara Narula explains why officials still say the benefits of vaccines outweigh the risks.

• Jun 24, 2021
• 01:49

U.S. divided over coronavirus vaccines

As CBS News' Manuel Bojorquez reports, the U.S. remains divided over coronavirus vaccines as experts worry this could trigger another surge. Then, Dr. Amesh Adalja, an infectious disease expert and senior scholar at Johns Hopkins University Bloomberg School of Public Health, joins CBSN's Elaine Quijano to discuss how to overcome the lag in shots and other coronavirus news headlines.

• Jun 21, 2021
• 07:45

FDA ignored advice to reject Alzheimer's drug

An FDA adviser who resigned in protest of an Alzheimer's drug approval says he's concerned about the agency's standards. Dr. Tara Narula explains why there are concerns about the drug's safety.

• Jun 21, 2021
• 05:07

FDA adviser who resigned over Alzheimer's drug approval speaks out

Dr. Aaron Kesselheim warned "there is a lot of evidence" the drug causes side effects and called the FDA's approval the "wrong decision."

• Jun 21, 2021

Face The Nation: Slavitt, Gottlieb

Missed the second half of the show? The latest on U.S. cities lifting pandemic restrictions, the global impact of the COVID-19 pandemic, the Trump administration handling of the coronavirus, the risk of new outbreaks from the Delta coronavirus variant and the political shakeup in Israel.

• Jun 13, 2021
• 22:34

COVID death toll nears 600,000 in U.S.

As CBS News' Nikki Battiste reports, the U.S. is well on its way to recovery from the coronavirus pandemic. However, the CDC and other health experts have new concerns for children. Dr. Anand Swaminathan, an emergency medicine physician, then joins CBSN's Lana Zak to discuss the day's other COVID headlines.

• Jun 10, 2021
• 10:27

FDA OK's first weight-loss drug in 7 years

The FDA has approved the first weight-loss drug in seven years for people who are either obese or overweight with at least one weight related medical condition. CBS News chief medical correspondent Dr. Jon LaPook joins "CBS This Morning" to explain how the drug works and who might benefit the most from it.

• Jun 9, 2021
• 03:55

FDA approves first Alzheimer's drug in 18 years

The FDA has approved a drug for people with Alzheimer's disease. Dr. Tara Narula explains how it could make a difference for those diagnosed with the disease and why some experts are skeptical about the evidence that led to approval.

• Jun 8, 2021
• 04:09

FDA approves drug to fight obesity

The new drug, Wegovy, has been approved for people who are either obese or overweight and have at least one weight-related medical problem. Dr. Jon LaPook has the details.

• Jun 8, 2021
• 02:01

FDA approves controversial Alzheimer's drug

The FDA approved the first Alzheimer's drug in nearly 20 years. The agency's decision drew controversy following warnings from independent advisers on the treatment known as Aduhelm. Dr. Jon LaPook has more.

• Jun 7, 2021
• 02:18

FDA approves new Alzheimer's drug

The Food and Drug Administration has granted approval to a drug called Aduhelm, developed by Biogen, for patients with Alzheimer's disease. The decision comes despite warnings from independent advisers that there isn't strong enough evidence to prove the treatment is effective in slowing the disease. Read more here.

• Jun 7, 2021
• 00:33

FDA approves first new Alzheimer's drug in 20 years, despite questions

Biogen's drug has aroused concerns, with some experts saying it isn't proven to slow the disease.

• Jun 7, 2021

Gottlieb calls for "broader view" of coronavirus origins

Dr. Scott Gottlieb, the former FDA commissioner, says "there is a lot of other information that points in the direction that this could have come out of a lab."

• Jun 6, 2021
• 07:13

Abortion pill sees new demand in U.S.

The Biden administration is ordering a review of FDA rules for accessing abortion pills via mail or telemedicine, as numerous states implement stricter regulations on abortion. Alice Miranda Ollstein, a health care reporter for Politico, joined CBSN to discuss what this means for the debate on abortion rights.

• Jun 3, 2021
• 08:55

Don't eat cicadas if you're allergic to seafood, FDA warns

Allergic to shrimp? You may want to avoid eating cicadas​, too.

• Jun 3, 2021

Moderna seeks full FDA approval for vaccine

Moderna has applied for full approval from the Food and Drug Administration for its COVID-19 vaccine, which is currently only authorized for emergency use in adults in the U.S. The pharmaceutical company said it will soon look into getting emergency-use authorization for its shot in children as young as 12. Dr. Dyan Hes, the founder of Gramercy Pediatrics in New York City, joined CBSN to discuss.

• Jun 1, 2021
• 06:00

Moderna finds vaccine safe, effective in kids 12 to 17

Moderna said its COVID-19 vaccine is 100% effective in children ages 12 to 17. If it receives FDA authorization, the U.S. will have two vaccines available for kids. Mola Lenghi has the latest.

• May 25, 2021
• 02:11

FDA plan to reduce nicotine in cigarettes

The FDA is taking what it calls "historic" first steps to make new rules to reduce nicotine in cigarettes to make them less addictive. The government estimates about five million people would quit smoking within a year of the new nicotine limits taking effect. David Agus joins "CBS This Morning" to discuss what the reduced levels of nicotine could mean for addiction and cancer rates.

• Mar 16, 2018
• 02:48

Scientists work to find "holy grail" flu vaccine

An FDA panel is expected to finalize next year's flu vaccine during a meeting Thursday. This will give manufacturers the six to nine months they need to prepare more than 150 million doses to fight the flu. Dr. Tara Narula reports.

• Mar 1, 2018
• 03:54

Show More